中国新经济投资(00080.HK)拟配售最多1.2亿股 总筹2161万港元
格隆汇 4 月 28日丨中国新经济投资(00080.HK)发布公告,2021年4月28日,公司与配售代理(即擎天证券有限公司)订立配售协议,据此,公司有条件同意透过配售代理按竭尽所能基准配售最多约1.20亿股配售股份予承配人,作价每股配售股份0.18港元。
配售价较股份于最后交易日收市价每股0.204港元折让11.8%。配售股份数目上限约1.20亿股占公司现有已发行股本约20%及经配售事项扩大的已发行股本约16.67%。
配售事项的最高所得款项总额将约为2161万港元,所得款项净额估计约为2121万港元,即每股配售股份的净发行价约为0.177港元。公司有意将配售事项的所得款项净额根据公司投资目标用于未来投资及业务发展以及用作公司一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.